TWD
GSK icon

True Wealth Design’s GSK GSK Stock Holding History

True Wealth Design’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.7K Buy
1,006
+55
+6% +$2.91K 0.01% 469
2026
Q1 		$52.5K Buy
951
+237
+33% +$12.8K 0.01% 387
2025
Q4 		$35K Buy
714
+2
+0.3% +$93 0.01% 439
2025
Q3 		$30.7K Buy
712
+605
+565% +$23.6K 0.01% 449
2025
Q2 		$4.11K Buy
107
+3
+3% +$115 ﹤0.01% 879
2025
Q1 		$4.03K Buy
104
+7
+7% +$256 ﹤0.01% 753
2024
Q4 		$3.28K Sell
97
-89
-48% -$3.2K ﹤0.01% 623
2024
Q3 		$7.6K Sell
186
-20,454
-99% -$837K ﹤0.01% 473
2024
Q2 		$795K Buy
20,640
+59
+0.3% +$2.48K 0.2% 82
2024
Q1 		$882K Sell
20,581
-423
-2% -$17.4K 0.22% 61
2023
Q4 		$778K Sell
21,004
-145
-0.7% -$5.21K 0.22% 81
2023
Q3 		$767K Sell
21,149
-260
-1% -$9.23K 0.26% 70
2023
Q2 		$763K Buy
21,409
+21,372
+57,762% +$767K 0.28% 74
2023
Q1 		$1.32K Hold
37
– – ﹤0.01% 369
2022
Q4 		$1.3K Buy
+37
New +$1.23K ﹤0.01% 321

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

True Wealth Design's GSK Position: Q2 2026 in Review

True Wealth Design increased its GSK (GSK) stake by 5.8% in Q2 2026, buying an estimated $2.91K and bringing the position to 1,006 shares worth $52.7K. The position accounts for 0.01% of the portfolio, ranked #469.

True Wealth Design first reported a position in GSK in Q4 2022 and has held it in 15 quarters since. The position peaked at $882K in Q1 2024. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • True Wealth Design held 1,006 shares of GSK worth $52.7K as of Q2 2026.
  • True Wealth Design bought 55 GSK shares in Q2 2026, an estimated $2.91K.
  • GSK made up 0.01% of True Wealth Design's portfolio in Q2 2026, its #469 holding.
  • True Wealth Design first reported a position in GSK in Q4 2022 and has held it in 15 quarters since.
  • True Wealth Design's GSK position peaked at $882K in Q1 2024.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.